Should we sequence everyone's genome? Yes

BMJ (Online)

Volumn 346, Issue 7909, 2013, Pages

  Burn, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NANOWIRE; VEMURAFENIB; WARFARIN;

BIOINFORMATICS; CARDIOMYOPATHY; DRUG SENSITIVITY; FAMILIAL CANCER; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOMICS; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; MALARIA; MEDICAL RESEARCH; MELANOMA; MONOGENIC DISORDER; NOTE; PRIORITY JOURNAL; RARE DISEASE; ARTICLE; DNA SEQUENCE; ETHICS; GENETIC DATABASE; GENETICS; HUMAN GENOME; INFORMED CONSENT; MEDICAL ETHICS; PERSONALIZED MEDICINE;

DATABASES, GENETIC; ETHICS, MEDICAL; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; INFORMED CONSENT; SEQUENCE ANALYSIS, DNA;

MLCS; MLOWN;

EID: 84878288344     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3133     Document Type: Note

References (5)

1. Chief Medical Officer. The 2009 annual report of the chief medical officer. Department of Health, 2010.
2. Xue Y, Chen Y, Ayub Q, Huang N, Ball EV, Mort M, et al. Deleterious and disease allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet 2012;91:1022-32.
3. Anderson JL, Horne BD, Stevens SM, Woller SC, Samuelson KM, Mansfield JW, et al. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualising warfarin dosing (CoumaGen II) Circulation 2012;125:1997-2005.
4. Cui Y, Wei QQ, Park HK, Lieber CM. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 2001;293:1289-92. (Pubitemid 32777412)
5. Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012;366:707-14.